JRFGlobal

Wishing You a Very Happy Diwali With Glow of Prosperity and Sparkle of Joy.

Read our Newsletter 9 | September 2021 – Pre-clinical and Regulatory Approach of Vaccines by Mr. Kunjan Shah.

Vaccines are biological pharmaceutical products prescribed as preventive and curative remedies for infections and diseases. The desired pharmacodynamic action of vaccines is the induction of a persistent immunological response against the targeted pathogen.

Click https://bit.ly/3ke9BDT and enjoy reading about the Pre-clinical and Regulatory Approach of Vaccines.

Read our Newsletter 8 | August 2021 – The Endocrine Disruptor Assay: Thyroid peroxidase (TPO) by Dr. Rahul Date

The endocrine system is a vital messenger system of the body, that utilizes a plethora of hormones. These signalling molecules travel through the bloodstream, as a communication tool to exert effects on distant cells, tissues, and organs.

Read our full newsletter https://bit.ly/3yJhGVT to get more knowledge on The Endocrine Disruptor Assay: Thyroid peroxidase (TPO).

Read our Newsletter 7 | July 2021 – Mouse Lymphoma Assay by Dr. Krishna Kumar Mishra.

Mouse Lymphoma Assay is an in vitro mammalian cell gene mutation test used to detect forward gene mutations (point mutations, frame-shift mutations, small deletions, etc.) and chromosomal events (large deletions, chromosome rearrangements and mitotic recombination).

Click https://bit.ly/3wyomnO and enjoy reading about the Mouse Lymphoma Assay.

Read our Newsletter 6 | June 2021 – Zebrafish Embryo-Larvae: Model of Ototoxicity by Nilambari Pawar. Click and enjoy reading!! Click https://bit.ly/3cCl8Zu

Hearing loss is a worldwide problem influencing quality life of the affected individual. It can occur due to aging (age-related hearing loss), environmental toxins or noise with high frequencies, but most commonly due to exposure to ototoxic drugs. Hair cells, the end organ of the auditory pathway is the affected target organ leading to hearing loss Unfortunately, several drugs used to treat life-threatening illnesses are known to damage hair cells. These include, aminoglycoside antibiotics, antimicrobials, loop diuretics, anti-inflammatory agents, antimalarial drugs, and platinum-based cytostatic drugs used as chemotherapeutic agents. Read full article https://bit.ly/3cCl8Zu to get more knowledge on the model of Ototoxicity.

JRF unites in fight against COVID-19
JRF completed the first dose of vaccination for employees last week.

Read our Newsletter | May 2021 K-REACH Enhanced safety for all by Mr. Yunju Jeong.

The article on K-REACH is divided into 3 parts. Click https://bit.ly/2SHkQJD and enjoy reading about the final part (Part 3) describes the major issues in the K-REACH act and the conclusion.

If you missed to read part 1 & 2, please refer below links

Part 1 https://bit.ly/3w1M2kL
Part 2 https://bit.ly/2SLrUoJ

Read our Newsletter (Part 2) | April 2021 K-REACH Enhanced safety for all by Mr. Yunju Jeong.

Click https://bit.ly/3nwwPVO and enjoy reading about the K-REACH Enhanced safety for all.

Read our Newsletter (Part 1) | March 2021 K-REACH Enhanced safety for all by Mr. Yunju Jeong.

The purpose of the K-REACH is to ensure that the chemical substances entering the Korean market are safe to the health and the environment of Korea. It is applicable for all the chemical substances manufactured and/or imported beyond 1 ton per year. All the new chemicals to be introduced in Korea are also obligated to comply with K-REACH.

Click https://bit.ly/3cyKnfr and enjoy reading about the K-REACH Enhanced safety.

of Statin Drugs / HMG-CoA reductase inhibitors including can be synthesised at JRFGlobal

The recent guidelines on bio-stimulant requires the manufacturer or importer to submit the information from the CIBRC certified laboratory. Kindly contact [email protected] for your requirement.